In the BioHarmony Drug Report Database

"Preview" Icon

Glibenclamide

Diabeta, Glyburide, Glynase, Micronase (glyburide) is a small molecule pharmaceutical. Glyburide was first approved as Diabeta on 1984-05-01. It is used to treat type 2 diabetes mellitus in the USA. The pharmaceutical is active against ATP-sensitive inward rectifier potassium channel 11. In addition, it is known to target cystic fibrosis transmembrane conductance regulator, ATP-sensitive inward rectifier potassium channel 8, solute carrier organic anion transporter family member 2B1, and aldo-keto reductase family 1 member C1.

 

Trade Name

 

Diabeta, Glyburide, Glynase, Micronase
 

Common Name

 

glyburide
 

ChEMBL ID

 

CHEMBL472
 

Indication

 

type 2 diabetes mellitus
 

Drug Class

 

Image (chem structure or protein)

Glibenclamide structure rendering